Tight control of STAT5 activity determines human CD34-derived interstitial dendritic cell and langerhans cell development

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7016-7024

  Van De Laar, Lianne ^a   Van Den Bosch, Aniek ^a   Wierenga, Albertus T J ^b   Janssen, Harry L A ^a   Coffer, Paul J ^c,d   Woltman, Andrea M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; JANUS KINASE 2; LANGERIN; STAT5 PROTEIN; TRANSCRIPTION FACTOR PU 1;

ARTICLE; CD34 SELECTION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; LANGERHANS CELL; LYMPHOCYTE ACTIVATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; LANGERHANS CELLS; PROTO-ONCOGENE PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 79959564172     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003977     Document Type: Article

References (47)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Naik, S. H. 2008. Demystifying the development of dendritic cell subtypes, a little. Immunol. Cell Biol. 86: 439-452.
3. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
4. Wu, L., and Y. J. Liu. 2007. Development of dendritic-cell lineages. Immunity 26: 741-750.
5. Watowich, S. S., and Y. J. Liu. 2010. Mechanisms regulating dendritic cell specification and development. Immunol. Rev. 238: 76-92.
6. Robbins, S. H., T. Walzer, D. Dembélé, C. Thibault, A. Defays, G. Bessou, H. Xu, E. Vivier, M. Sellars, P. Pierre, et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9: R17.
7. Merad, M., and M. G. Manz. 2009. Dendritic cell homeostasis. Blood 113: 3418-3427.
8. Auffray, C., D. K. Fogg, E. Narni-Mancinelli, B. Senechal, C. Trouillet, N. Saederup, J. Leemput, K. Bigot, L. Campisi, M. Abitbol, et al. 2009. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J. Exp. Med. 206: 595-606.
9. Fogg, D. K., C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann. 2006. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87. (Pubitemid 43063063)
10. Naik, S. H., P. Sathe, H. Y. Park, D. Metcalf, A. I. Proietto, A. Dakic, S. Carotta, M. O'Keeffe, M. Bahlo, A. Papenfuss, et al. 2007. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat. Immunol. 8: 1217-1226.
11. Onai, N., A. Obata-Onai, M. A. Schmid, T. Ohteki, D. Jarrossay, and M. G. Manz. 2007. Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat. Immunol. 8: 1207-1216.
12. Moore, M. A., D. C. Dorn, J. J. Schuringa, K. Y. Chung, and G. Morrone. 2007. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp. Hematol. 35(4, Suppl 1): 105-116.
13. Olthof, S. G., S. Fatrai, A. L. Drayer, M. R. Tyl, E. Vellenga, and J. J. Schuringa. 2008. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis. Stem Cells 26: 1732-1742.
14. Wierenga, A. T., E. Vellenga, and J. J. Schuringa. 2008. Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels. Mol. Cell. Biol. 28: 6668-6680.
15. Bradley, H. L., T. S. Hawley, and K. D. Bunting. 2002. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. Blood 100: 3983-3989.
16. Schuringa, J. J., K. Y. Chung, G. Morrone, and M. A. Moore. 2004. Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J. Exp. Med. 200: 623-635.
17. Buitenhuis, M., B. Baltus, J. W. Lammers, P. J. Coffer, and L. Koenderman. 2003. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood 101: 134-142.
18. Martinez-Moczygemba, M., and D. P. Huston. 2003. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J. Allergy Clin. Immunol. 112: 653-665, quiz 666.
19. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184: 1953-1962.
20. Vremec, D., G. J. Lieschke, A. R. Dunn, L. Robb, D. Metcalf, and K. Shortman. 1997. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27: 40-44.
21. Kingston, D., M. A. Schmid, N. Onai, A. Obata-Onai, D. Baumjohann, and M. G. Manz. 2009. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 114: 835-843.
22. Esashi, E., Y. H. Wang, O. Perng, X. F. Qin, Y. J. Liu, and S. S. Watowich. 2008. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28: 509-520.
23. Caux, C., B. Vanbervliet, C. Massacrier, C. Dezutter-Dambuyant, B. de Saint- Vis, C. Jacquet, K. Yoneda, S. Imamura, D. Schmitt, and J. Banchereau. 1996. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 184: 695-706.
24. van de Laar, L., M. Buitenhuis, F. M. Wensveen, H. L. Janssen, P. J. Coffer, and A. M. Woltman. 2010. Human CD34-derived myeloid dendritic cell development requires intact phosphatidylinositol 3-kinase-protein kinase B-mammalian target of rapamycin signaling. J. Immunol. 184: 6600-6611.
25. Moriggl, R., V. Gouilleux-Gruart, R. Jähne, S. Berchtold, C. Gartmann, X. Liu, L. Hennighausen, A. Sotiropoulos, B. Groner, and F. Gouilleux. 1996. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol. Cell. Biol. 16: 5691-5700.
26. van de Laar, L., A. van den Bosch, S. W. van der Kooij, H. L. Janssen, P. J. Coffer, C. van Kooten, and A. M. Woltman. 2010. A nonredundant role for canonical NF-kB in human myeloid dendritic cell development and function. J. Immunol. 185: 7252-7261.
27. Strobl, H., E. Riedl, C. Scheinecker, C. Bello-Fernandez, W. F. Pickl, K. Rappersberger, O. Majdic, and W. Knapp. 1996. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157: 1499-1507. (Pubitemid 126449086)
28. Heinz, L. X., B. Platzer, P. M. Reisner, A. Jörgl, S. Taschner, F. Göbel, and H. Strobl. 2006. Differential involvement of PU.1 and Id2 downstream of TGF-beta1 during Langerhans-cell commitment. Blood 107: 1445-1453. (Pubitemid 43242380)
29. Chen, H. M., H. L. Pahl, R. J. Scheibe, D. E. Zhang, and D. G. Tenen. 1993. The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J. Biol. Chem. 268: 8230-8239.
30. Pahl, H. L., R. J. Scheibe, D. E. Zhang, H. M. Chen, D. L. Galson, R. A. Maki, and D. G. Tenen. 1993. The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J. Biol. Chem. 268: 5014-5020.
31. Carotta, S., A. Dakic, A. D'Amico, S. H. Pang, K. T. Greig, S. L. Nutt, and L. Wu. 2010. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32: 628-641.
32. Cohen, P. A., G. K. Koski, B. J. Czerniecki, K. D. Bunting, X. Y. Fu, Z. Wang, W. J. Zhang, C. S. Carter, M. Awad, C. A. Distel, et al. 2008. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 112: 1832-1843.
33. Cocolakis, E., M. Dai, L. Drevet, J. Ho, E. Haines, S. Ali, and J. J. Lebrun. 2008. Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation. J. Biol. Chem. 283: 1293-1307.
34. Song, C., S. Y. Jun, J. H. Hong, and H. Ahn. 2007. Transforming growth factor-beta downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma. J. Cancer Res. Clin. Oncol. 133: 487-492.
35. Wu, W. J., C. F. Lee, C. H. Hsin, J. Y. Du, T. C. Hsu, T. H. Lin, T. Y. Yao, C. H. Huang, and Y. J. Lee. 2008. TGF-beta inhibits prolactin-induced expression of beta-casein by a Smad3-dependent mechanism. J. Cell. Biochem. 104: 1647-1659.
36. Anderson, K. L., H. Perkin, C. D. Surh, S. Venturini, R. A. Maki, and B. E. Torbett. 2000. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 164: 1855-1861.
37. Bakri, Y., S. Sarrazin, U. P. Mayer, S. Tillmanns, C. Nerlov, A. Boned, and M. H. Sieweke. 2005. Balance of MafB and PU.1 specifies alternative macrophage or dendritic cell fate. Blood 105: 2707-2716.
38. Iwama, A., M. Osawa, R. Hirasawa, N. Uchiyama, S. Kaneko, M. Onodera, K. Shibuya, A. Shibuya, C. Vinson, D. G. Tenen, and H. Nakauchi. 2002. Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment. J. Exp. Med. 195: 547-558.
39. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
40. Platzer, B., S. Richter, D. Kneidinger, D. Waltenberger, M. Woisetschläger, and H. Strobl. 2009. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 183: 66-74.
41. Wierenga, A. T., E. Vellenga, and J. J. Schuringa. 2010. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation. Blood 115: 4367-4376.
42. Hamilton, J. A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8: 533-544.
43. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7: 19-30.
44. Hong, B., W. Ren, X. T. Song, K. Evel-Kabler, S. Y. Chen, and X. F. Huang. 2009. Human suppressor of cytokine signaling 1 controls immunostimulatory activity of monocyte-derived dendritic cells. Cancer Res. 69: 8076-8084.
45. Zhong, J., P. Yang, K. Muta, R. Dong, M. Marrero, F. Gong, and C. Y. Wang. 2010. Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS ONE 5: e9593.
46. Bontkes, H. J., J. J. Ruizendaal, D. Kramer, S. J. Santegoets, R. J. Scheper, T. D. de Gruijl, C. J. Meijer, and E. Hooijberg. 2006. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells. J. Immunother. 29: 188-200.
47. Jongbloed, S. L., A. J. Kassianos, K. J. McDonald, G. J. Clark, X. Ju, C. E. Angel, C. J. Chen, P. R. Dunbar, R. B. Wadley, V. Jeet, et al. 2010. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207: 1247-1260.